Medicare spending for hospital outpatient services will increase by nearly 6 percent in 2003 under a final regulation published by the Centers for Medicare & Medicaid Services late in October. However, the new rate schedule will reduce reimbursement of some drugs significantly, including blood products, medical devices, and high-technology procedures that do not require an overnight stay.
Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
The FDA approval, based on 36-week data from the phase 3 BRAVE-AA-PEDS trial, extends baricitinib access to patients as young as 12 years old with severe alopecia areata.
Three experimental hair loss mechanisms are moving through late-stage trials for the first time in decades, and the data are worth knowing before patients ask.
Alexandra Charrow, MD, discussed biologic selection, deroofing, and emerging procedural approaches to hidradenitis suppurativa at Maui Derm NP+PA Fall 2026.